BIOTRICITY INC. Quarterly Debt-to-equity in % from Q1 2016 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Biotricity Inc. quarterly Debt-to-equity history and growth rate from Q1 2016 to Q3 2024.
  • Biotricity Inc. Debt-to-equity for the quarter ending September 30, 2024 was -113 %, a 12.8% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 -113 +16.5 +12.8% Sep 30, 2024
Q2 2024 -115 +24.1 +17.3% Jun 30, 2024
Q1 2024 -119 +44.7 +27.3% Mar 31, 2024
Q4 2023 -123 +102 +45.3% Dec 31, 2023
Q3 2023 -129 +311 +70.7% Sep 30, 2023
Q2 2023 -139 -4.74K -103% Jun 30, 2023
Q1 2023 -164 +1.97K +92.3% Mar 31, 2023
Q4 2022 -225 +448 +66.5% Dec 31, 2022
Q3 2022 -441 -212 -92.4% Sep 30, 2022
Q2 2022 4.6K +4.74K Jun 30, 2022
Q1 2022 -2.13K -1.99K -1385% Mar 31, 2022
Q4 2021 -673 -532 -378% Dec 31, 2021
Q3 2021 -229 -65.5 -40% Sep 30, 2021
Q2 2021 -141 +26.9 +16.1% Jun 30, 2021
Q1 2021 -144 +30.2 +17.4% Mar 31, 2021
Q4 2020 -141 +27.9 +16.6% Dec 31, 2020
Q3 2020 -163 -35.1 -27.3% Sep 30, 2020
Q2 2020 -167 -30.2 -22% Jun 30, 2020
Q1 2020 -174 -31.7 -22.3% Mar 31, 2020
Q4 2019 -169 +35.6 +17.4% Dec 31, 2019
Q3 2019 -128 -577 -129% Sep 30, 2019
Q2 2019 -137 -380 -157% Jun 30, 2019
Q1 2019 -142 +314 +68.9% Mar 31, 2019
Q4 2018 -204 -22.5 -12.4% Dec 31, 2018
Q3 2018 448 +568 Sep 30, 2018
Q2 2018 243 +355 Jun 30, 2018
Q1 2018 -456 -351 -334% Mar 31, 2018
Q4 2017 -182 -94.1 -108% Dec 31, 2017
Q3 2017 -120 -31.9 -36.1% Sep 30, 2017
Q2 2017 -113 -28.8 -34.2% Jun 30, 2017
Q1 2017 -105 -35.6 -51.2% Mar 31, 2017
Q4 2016 -87.4 Dec 31, 2016
Q3 2016 -88.4 Sep 30, 2016
Q2 2016 -84.1 Jun 30, 2016
Q1 2016 -69.5 Mar 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.